Patent ID: 8785394

Claim:
A method of treating a condition selected from the group consisting of dry eye, blepharitis, meibomian gland disease, impaired corneal sensitivity, allergic conjunctivitis, atopic keratoconjunctivitis, vernal keratoconjunctivitis, and ptyregia, the method comprising the step of administering to a subconjunctival space of an eye of a patient having the condition a formulation comprising cyclosporin A form 2 and a hydrogel, the hydrogel selected from the group consisting of hyaluronic acid, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, hydroxyethylcellulose, polyvinyl pyrolidone, carboxymethylcellulose hydroxyethyl cellulose, and polyvinylpyrrolidone.